For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Channel Therapeutics Corporation (AMEX: CHRO) closed at $2.70 in the last session, up 1.50% from day before closing price of $2.66. In other words, the price has increased by $1.50 from its previous closing price. On the day, 0.92 million shares were traded. CHRO stock price reached its highest trading level at $2.8 during the session, while it also had its lowest trading level at $2.0901.
Ratios:
We take a closer look at CHRO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.39 and its Current Ratio is at 0.39.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 12 ’24 when Malamut Richard bought 10,400 shares for $0.94 per share. The transaction valued at 9,825 led to the insider holds 91,565 shares of the business.
Francis Knuettel II bought 3,500 shares of CHRO for $3,395 on Sep 13 ’24. The CEO, Pres., CFO, Treas & Secty now owns 547,710 shares after completing the transaction at $0.97 per share. On Sep 12 ’24, another insider, Francis Knuettel II, who serves as the CEO, Pres., CFO, Treas & Secty of the company, bought 1,700 shares for $0.97 each. As a result, the insider paid 1,649 and bolstered with 544,210 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CHRO now has a Market Capitalization of 16275627 and an Enterprise Value of 2883994.
Stock Price History:
Over the past 52 weeks, CHRO has reached a high of $6.00, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is 238.81%, while the 200-Day Moving Average is calculated to be 149.41%.
Shares Statistics:
According to the various share statistics, CHRO traded on average about 881.58K shares per day over the past 3-months and 4772020 shares per day over the past 10 days. A total of 5.82M shares are outstanding, with a floating share count of 1.80M. Insiders hold about 70.11% of the company’s shares, while institutions hold 1.98% stake in the company. Shares short for CHRO as of 1730332800 were 58233 with a Short Ratio of 0.00, compared to 1727654400 on 31672. Therefore, it implies a Short% of Shares Outstanding of 58233 and a Short% of Float of 1.3300001000000001.
Earnings Estimates
The current rating of Channel Therapeutics Corporation (CHRO) is the result of assessments by 1 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.29, with high estimates of -$0.29 and low estimates of -$0.29.
Analysts are recommending an EPS of between -$1.3 and -$1.3 for the fiscal current year, implying an average EPS of -$1.3. EPS for the following year is -$1.1, with 1.0 analysts recommending between -$1.1 and -$1.1.
